Long-Acting Cabotegravir Plus VRC-HIVMAB075-00-AB (VRC07-523LS) for Viral Suppression in Adults Living With HIV-1
Clinical trial NCT03739996 · COMPLETED
Trial details
- NCT number
- NCT03739996
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-31
- Primary completion
- 2024-04-29
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.